Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 35260Generated: October 25, 2026

Triethylamine → N-ethyl-N-cyclohexyl-5-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)valeramide

https://huagongshe.com/reaction/35260

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTriethylamineHCID 8471—
ReactantN-Ethyl cyclohexylamineHCID 21609—
ReactantIsobutyl chloroformateHCID 62365—
Reactant5-(1-Cyclohexyl-1,2,3,4-tetrazol-5-yl)valeric acidHCID 13203402—
SolventTetrahydrofuranHCID 8028—
ProductN-ethyl-N-cyclohexyl-5-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)valeramideHCID 1320339772.6%

Reaction Steps

5-(1-Cyclohexyl-1,2,3,4-tetrazol-5-yl)valeric acid (2.5 g) is dissolved in tetrahydrofuran (50 ml), and thereto is added triethylamine (1.1 g). To the mixture is added dropwise with stirring isobutyl chloroformate (1.5 g) under ice-cooling, and the mixture is stirred at room temperature for 30 minutes. To the mixture is added dropwise with stirring N-ethyl-cyclohexylamine (1.5 g) at room temperature, and the mixture is further stirred for 2 hours. After distilling off tetrahydrofuran, water is added to the residue, and the mixture is extracted with chloroform. The chloroform layer is washed with an aqueous saturated sodium chloride solution and dried over magnesium sulfate. Chloroform is distilled off, and the resulting residue is subjected to column chromatography (Kieselgel 60, made by Merck & Co., eluting solvent, chloroform) to isolate N-ethyl-N-cyclohexyl-5-(1-cyclohexyl-1,2,3,4-tetrazol-5-yl)valeramide (2.6 g), white crystalline powder (ether), m.p. 92°-95° C.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS04766120
Source datasetuspto-grants-1988_08
ORD IDord-25fc57d6c3534e629f1814f0d825248e
Source noteuspto-grants-1988_08